Literature DB >> 22514029

On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data.

Geert Molenberghs1, Michael G Kenward, Marc Aerts, Geert Verbeke, Anastasios A Tsiatis, Marie Davidian, Dimitris Rizopoulos.   

Abstract

The vast majority of settings for which frequentist statistical properties are derived assume a fixed, a priori known sample size. Familiar properties then follow, such as, for example, the consistency, asymptotic normality, and efficiency of the sample average for the mean parameter, under a wide range of conditions. We are concerned here with the alternative situation in which the sample size is itself a random variable which may depend on the data being collected. Further, the rule governing this may be deterministic or probabilistic. There are many important practical examples of such settings, including missing data, sequential trials, and informative cluster size. It is well known that special issues can arise when evaluating the properties of statistical procedures under such sampling schemes, and much has been written about specific areas (Grambsch P. Sequential sampling based on the observed Fisher information to guarantee the accuracy of the maximum likelihood estimator. Ann Stat 1983; 11: 68-77; Barndorff-Nielsen O and Cox DR. The effect of sampling rules on likelihood statistics. Int Stat Rev 1984; 52: 309-326). Our aim is to place these various related examples into a single framework derived from the joint modeling of the outcomes and sampling process and so derive generic results that in turn provide insight, and in some cases practical consequences, for different settings. It is shown that, even in the simplest case of estimating a mean, some of the results appear counterintuitive. In many examples, the sample average may exhibit small sample bias and, even when it is unbiased, may not be optimal. Indeed, there may be no minimum variance unbiased estimator for the mean. Such results follow directly from key attributes such as non-ancillarity of the sample size and incompleteness of the minimal sufficient statistic of the sample size and sample sum. Although our results have direct and obvious implications for estimation following group sequential trials, there are also ramifications for a range of other settings, such as random cluster sizes, censored time-to-event data, and the joint modeling of longitudinal and time-to-event data. Here, we use the simplest group sequential setting to develop and explicate the main results. Some implications for random sample sizes and missing data are also considered. Consequences for other related settings will be considered elsewhere.

Entities:  

Keywords:  Frequentist inference; generalized sample average; informative cluster size; joint modeling; likelihood inference; missing at random; random cluster size

Mesh:

Year:  2012        PMID: 22514029      PMCID: PMC3404233          DOI: 10.1177/0962280212445801

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  3 in total

Review 1.  A unified theory for sequential clinical trials.

Authors:  J Whitehead
Journal:  Stat Med       Date:  1999 Sep 15-30       Impact factor: 2.373

2.  Stopping rules and estimation problems in clinical trials.

Authors:  M D Hughes; S J Pocock
Journal:  Stat Med       Date:  1988-12       Impact factor: 2.373

3.  Exact confidence intervals following a group sequential test.

Authors:  A A Tsiatis; G L Rosner; C R Mehta
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

  3 in total
  2 in total

1.  Estimation After a Group Sequential Trial.

Authors:  Elasma Milanzi; Geert Molenberghs; Ariel Alonso; Michael G Kenward; Anastasios A Tsiatis; Marie Davidian; Geert Verbeke
Journal:  Stat Biosci       Date:  2014-02-22

2.  Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules.

Authors:  Elasma Milanzi; Geert Molenberghs; Ariel Alonso; Michael G Kenward; Geert Verbeke; Anastasios A Tsiatis; Marie Davidian
Journal:  J Biom Biostat       Date:  2016-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.